Tanaka Y - Search Results

1

Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.

Nishio N, Fujita M, Tanaka Y, Maki H, Zhang R, Hirosawa T, Demachi-Okamura A, Uemura Y, Taguchi O, Takahashi Y, Kojima S, Kuzushima K. Nishio N, et al. Among authors: tanaka y. J Immunother. 2012 Oct;35(8):598-606. doi: 10.1097/CJI.0b013e31826a745a. J Immunother. 2012. PMID: 22996365

2

Human gamma delta T cells and tumor immunotherapy.

Tanaka Y. Tanaka Y. J Clin Exp Hematop. 2006 Mar;46(1):11-23. doi: 10.3960/jslrt.46.11. J Clin Exp Hematop. 2006. PMID: 17058804 Free article.

3

Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.

Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M, Minato N. Iwasaki M, et al. Among authors: tanaka y. Eur J Immunol. 2011 Feb;41(2):345-55. doi: 10.1002/eji.201040959. Epub 2011 Jan 11. Eur J Immunol. 2011. PMID: 21268005 Free article.

4

Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.

Sugie T, Murata-Hirai K, Iwasaki M, Morita CT, Li W, Okamura H, Minato N, Toi M, Tanaka Y. Sugie T, et al. Among authors: tanaka y. Cancer Immunol Immunother. 2013 Apr;62(4):677-87. doi: 10.1007/s00262-012-1368-4. Epub 2012 Nov 15. Cancer Immunol Immunother. 2013. PMID: 23151944 Free PMC article.

5

Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.

Idrees AS, Sugie T, Inoue C, Murata-Hirai K, Okamura H, Morita CT, Minato N, Toi M, Tanaka Y. Idrees AS, et al. Among authors: tanaka y. Cancer Sci. 2013 May;104(5):536-42. doi: 10.1111/cas.12124. Epub 2013 Mar 19. Cancer Sci. 2013. PMID: 23387443 Free PMC article.

6

Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.

Nada MH, Wang H, Workalemahu G, Tanaka Y, Morita CT. Nada MH, et al. Among authors: tanaka y. J Immunother Cancer. 2017 Feb 21;5:9. doi: 10.1186/s40425-017-0209-6. eCollection 2017. J Immunother Cancer. 2017. PMID: 28239463 Free PMC article.

7

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.

Tanaka Y, Murata-Hirai K, Iwasaki M, Matsumoto K, Hayashi K, Kumagai A, Nada MH, Wang H, Kobayashi H, Kamitakahara H, Okamura H, Sugie T, Minato N, Toi M, Morita CT. Tanaka Y, et al. Cancer Sci. 2018 Mar;109(3):587-599. doi: 10.1111/cas.13491. Epub 2018 Feb 4. Cancer Sci. 2018. PMID: 29288540 Free PMC article.

8

Determination of human γδ T cell-mediated cytotoxicity using a non-radioactive assay system.

Tagod MSO, Mizuta S, Sakai Y, Iwasaki M, Shiraishi K, Senju H, Mukae H, Morita CT, Tanaka Y. Tagod MSO, et al. Among authors: tanaka y. J Immunol Methods. 2019 Mar;466:32-40. doi: 10.1016/j.jim.2019.01.003. Epub 2019 Jan 14. J Immunol Methods. 2019. PMID: 30654042 Free PMC article.

9

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells.

Okuno D, Sugiura Y, Sakamoto N, Tagod MSO, Iwasaki M, Noda S, Tamura A, Senju H, Umeyama Y, Yamaguchi H, Suematsu M, Morita CT, Tanaka Y, Mukae H. Okuno D, et al. Among authors: tanaka y. Front Immunol. 2020 Jul 21;11:1405. doi: 10.3389/fimmu.2020.01405. eCollection 2020. Front Immunol. 2020. PMID: 32793196 Free PMC article.

10

Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.

Kato Y, Tanaka Y, Tanaka H, Yamashita S, Minato N. Kato Y, et al. Among authors: tanaka h, tanaka y. J Immunol. 2003 Apr 1;170(7):3608-13. doi: 10.4049/jimmunol.170.7.3608. J Immunol. 2003. PMID: 12646624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,318 results

Search Page

Filters